EUVIMEDDescoperă EUVIMED
Übersichtsarbeit

Role of Glutathione in Parkinson's Disease Pathophysiology and Therapeutic Potential of Polyphenols

Chengu Niu iD, Miaoxian Dong iD, Yingcai Niu iD

Phytotherapy Research · 2024-12 · 38 (12) · 5567-5582

DOI: 10.1002/ptr.8342 ↗

At a glance

Übersichtsarbeit in Phytotherapy Research, published online on 2024-09-17. Written by Chengu Niu and 2 co-authors. Institution: Internal Medicine Residency Program, Rochester General Hospital, Rochester, New York, USA. Major MEDLINE topics: Antioxidants, Brain, Glutathione, Neuroprotective Agents. Cited 14 times so far (Crossref); 129 references. Funded by: National Natural Science Foundation of China.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Oxidative stress is recognized to have a central role in the initiation and progression of Parkinson's disease (PD). Within the brain, neurons are particularly sensitive to oxidation due in part to their weak intrinsic antioxidant defense. Theoretically, neurons mostly depend on neighboring astrocytes to provide antioxidant protection by supplying cysteine‐containing products for glutathione (GSH) synthesis. Astrocytes and neurons possess several amino acid transport systems for GSH and its precursors. Indeed, GSH is the most abundant intrinsic antioxidant in the central nervous system. The GSH depletion and/or alterations in its metabolism in the brain contribute to the pathogenesis of PD. Noteworthy, polyphenols possess potent antioxidant activity and can augment the GSH redox system. Numerous in vitro and in vivo studies have indicated that polyphenols exhibit potent neuroprotective effects in PD. Epidemiological studies have found an association between the consumption of dietary polyphenols and a lower PD risk. In this review, we summarize current knowledge on the biosynthesis and metabolism of GSH in the brain, with an emphasis on their contribution and therapeutic potential in PD. In particular, we focus on polyphenols that can increase brain GSH levels against PD. Furthermore, some current challenges and future perspectives for polyphenol‐based therapies are also discussed.

Subjects

MeSH terms (MEDLINE)

AntioxidantsBrainGlutathioneNeuroprotective AgentsParkinson DiseasePolyphenolsAnimalsHumansAstrocytesNeuronsOxidative Stress

Author keywords

Parkinson's diseaseastrocytesglutathioneneuronspolyphenols

Substances

AntioxidantsGlutathioneNeuroprotective AgentsPolyphenols

Authors and institutions

  • Internal Medicine Residency Program, Rochester General Hospital, Rochester, New York, USA.
  • The Institute of Medicine, Qiqihar Medical University, Qiqihar, China.

ORCID profiles: Chengu Niu, Miaoxian Dong, Yingcai Niu

Funding

  • National Natural Science Foundation of China

Cite

APA

Niu, C., Dong, M., & Niu, Y. (2024). Role of Glutathione in Parkinson's Disease Pathophysiology and Therapeutic Potential of Polyphenols. Phytotherapy Research, 38(12), 5567-5582. https://doi.org/10.1002/ptr.8342

Vancouver

Niu C, Dong M, Niu Y. Role of Glutathione in Parkinson's Disease Pathophysiology and Therapeutic Potential of Polyphenols. Phytotherapy Research. 2024;38(12):5567-5582. doi:10.1002/ptr.8342

BibTeX
@article{Niu2024,
  author = {Niu, Chengu and Dong, Miaoxian and Niu, Yingcai},
  title = {Role of Glutathione in Parkinson's Disease Pathophysiology and Therapeutic Potential of Polyphenols},
  journal = {Phytotherapy Research},
  year = {2024},
  volume = {38},
  number = {12},
  pages = {5567--5582},
  doi = {10.1002/ptr.8342}
}
Start for free →